Allergy Prevention and Exacerbation

Presents an overview of current theories on causes of allergyIncludes epidemiological findings and forecastDiscusses the connection between microbiome and allergy

Presents an overview of current theories on causes of allergy Includes epidemiological findings and forecast Discusses the connection between microbiome and allergy

Autorentext

Prof. Carsten Schmidt-Weber has been the director of the Center for Allergy and Environment (ZAUM) since 2010 and is a steering member of the Allergy and ImmunityCluster. Prof. Schmidt-Weber studied biochemistry and immunology in Darmstadt and Erlangen, Germany. He then attended the Harvard Medical School in Boston as a postdoctoral fellow and worked at the Swiss Institute for Allergy and Asthma in Davos, where he pursued theresearch for his postdoctoral teaching qualification (habilitation). From October 2007 to March 2010 he worked as areader at the Imperial College in London. Since 2010 he has been professor of the newly founded Chair of Molecular Allergology at TUM and Helmholtz Center Munich. He is a member of the Collegium International Allergologicum, the German Society for Immunology (DGFI) and the German Society of Allergology and Clinical Immunology (DGAKI). He has published over 50 original works, as well as review and book articles in prestigious professional journals.

Inhalt
Chapter 1: Overview:The paradox of microbial impact on the immune system in allergy prevention and exacerbation.- Chapter 2: Microbial triggers in Autoimmunity, severe Aller-gy, and Autoallergy.- Chapter 3: Bacterial allergens.- Chapter 4: Good and bad farming: the right microbiome protects from allergy.- Chapter 5: The lost friend: H. pylori.- Chapter 6: Parasite mediated protection against allergy.- Chapter 7: Initiation, persistence and exacerbation of food allergy.- Chapter 8: The role of the gut in type 2 immunity.- Chapter 9: Aryl hydrocarbon receptor: an environmental sensor in control of allergy outcomes.- Chapter 10: The gut microbiome and its marriage to the im-mune system: can we change it all?.- Chapter 11: Specific therapies for asthma endotypes: a new twist in drug development.